Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, announced the extension of a collaboration with a major biopharmaceutical partner for the ...

The €4 million (US$4.3 million) project is current good manufacturing practice compliant, and includes an accompanying cartoning machine. The Munich-based contract development and manufacturing ...

Lonza, announced the operational readiness of its new aseptic drug product filling line in Stein (CH). The filling line was granted a GMP license following Swissmedic approval, strengthening Lonza’s ...

The new cGMP filling line at Lonza’s Stein (CH) site will enable handling and filling of bioconjugates for commercial supply Expansion of filling capacity will enhance Lonza's end-to-end integrated ...